0001127602-23-016281.txt : 20230519
0001127602-23-016281.hdr.sgml : 20230519
20230519161111
ACCESSION NUMBER: 0001127602-23-016281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230519
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ICAHN BRETT
CENTRAL INDEX KEY: 0001387184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 23940156
MAIL ADDRESS:
STREET 1: C/O ICAHN ENTERPRISES L.P.
STREET 2: 16690 COLLINS AVE., PH
CITY: SUNNY ISLES
STATE: FL
ZIP: 33160
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-19
0000885590
Bausch Health Companies Inc.
BHC
0001387184
ICAHN BRETT
400 SOMERSET CORPORATE BLVD
BRIDGEWATER
NJ
08807
1
0
Common Shares, No Par Value
2023-05-19
4
A
0
29205
0
A
93079
D
Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.
/s/ Brianna M. Cetrulo, attorney-in-fact
2023-05-19